Drug Shortage Report for SANDOZ VENLAFAXINE XR

Last updated on 2020-01-22 History
Report ID 86402
Drug Identification Number 02310317
Brand name SANDOZ VENLAFAXINE XR
Common or Proper name VENLAFAXINE XR
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) VENLAFAXINE
Strength(s) 37.5MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 100
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-06-03
Estimated end date 2019-12-20
Actual end date 2020-01-16
Shortage status Resolved
Updated date 2020-01-22
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-01-22 French Compare
v9 2020-01-22 English Compare
v8 2019-10-15 French Compare
v7 2019-10-15 English Compare
v6 2019-09-25 French Compare
v5 2019-09-25 English Compare
v4 2019-07-16 French Compare
v3 2019-07-16 English Compare
v2 2019-06-12 French Compare
v1 2019-06-12 English Compare